Urinary Excretion of Nitric Oxide, Cyclic Gmp, and Catecholamines During Rest and Activity Period in Transgenic Hypertensive Rats

Reference

• Ackermann H. BiAS. Biometrische Analyse von Stichproben. Epsilon-Verlag, Hochheim-Darmstadt 1997
   Google Scholar
• Aschoff J. Day-night variations in the cardiovascular system. Historical and other notes by an outsider. Temporal variations of cardiovascular system, T FH Schmidt, B T Engel, G Blümchen. Springer Verlag, Berlin 1992; 3–14
   Google Scholar
• Bell G M, Atlas S A, Pecker M. Diurnal and postural variations in plasma atrial natriuretic factor, plasma guanosine 3′5′-cyclic monophoshate and sodium excretion. Clin Sci. 1990; 79: 371–76
   Google Scholar
• Böger RH, Bode-Böger SM, Gerecke U. Urinary NO−3 excretion as an indicator of nitric oxide formation in vivo during oral administration of l-arginine or l-name in rats. Clin Exp Pharmacol Physiol. 1996; 23: 11–15
   PubMed Web of Science ®Google Scholar
• Böhm M, Lippoldt A, Wienen W. Reduction of cardiac hypertrophy in TGR(mREN2)27 by angiotensin II receptor blockade. Mol Cell Biochem. 1996; 163/164: 217–21
   Web of Science ®Google Scholar
• Broadus A E, Kaminsky N I, Hardman J G. Kinetic parameters of plasma adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in man. J Clin Invest. 1970; 49: 2222–36
   PubMed Web of Science ®Google Scholar
• Casiglia E, Palatini P, Baccillieri M S. Circadian rhythms of peripheral resistance: a non-invasive 24-hour study in young normal volunteers confined to bed. High Blood Press. 1992; 1: 249–55
   Google Scholar
• Chinkers M, Garbers D L, Chang M S. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 1989; 338: 78–83
   PubMed Web of Science ®Google Scholar
• Dominiczak A F, Bohr D F. Nitric oxide and its putative role in hypertension. Hypertension. 1995; 25: 1202–9
   PubMed Web of Science ®Google Scholar
• Green L C, Wagner D A, Glogowski J. Analysis of nitrate, nitrite and 15N-nitrate in biological fluids. Anal Biochem. 1982; 126: 131–38
   PubMed Web of Science ®Google Scholar
• Helger R, Rindfrey H, Hilgenfeld J. Eine Methode zur direkten Bestimmung des Creatinins im Serum und Urin ohne Enteiweissung nach einer modifizierten Jaffé-Methode. 2 Clin Biochem. 1974; 12: 344
   Google Scholar
• Hilfenhaus M. Circadian rhythm of the renin-angiotensin-aldosterone system in rat. Arch Toxicol. 1976; 36: 305–16
   PubMed Web of Science ®Google Scholar
• Kopp L, Lin T, Tucci J R. Circadian rhythms in urinary excretion of cyclic 3′,5′-adenosine monophosphate (cyclic AMP) and cyclic 3′,5′-guanosine monophoshate (cyclic GMP) in human subjects. J Clin Endocrinol Metab. 1977; 44: 673–80
   PubMedGoogle Scholar
• Kuwajima I, Suzuki Y, Shimosava T. Diminished nocturnal decline in blood pressure in elderly hypertensive patients with left ventricular hypertrophy. Am Heart J. 1992; 67: 1307–11
   Google Scholar
• Lemmer B, Brühl T, Witte K. Effects of bright light on circadian patterns of cyclic adenosine monophosphate, melatonin and cortisol in healthy subjects. Eur J Endocrinol. 1994; 130: 472–77
   PubMed Web of Science ®Google Scholar
• Lemmer B, Mattes A, Böhm M. Circadian blood pressure variation in transgenic hypertensive rats. Hypertension. 1993; 22: 97–101
   PubMed Web of Science ®Google Scholar
• Lemmer B, Portaluppi B. Chronopharmacology of cardiovascular diseases. Handbook of experimental pharmacology, Vol. 125. Physiology and pharmacology of biological rhythms, P H Redfern, B Lemmer. Springer Verlag, Berlin 1997; 251–97
   Google Scholar
• Lemmer B, Witte K, Makabe T. Effects of enalaprilat on circadian profiles in blood pressure and heart rate of spontaneously and transgenic hypertensive rats. J Cardiovasc Pharmacol. 1994; 23: 311–14
   PubMed Web of Science ®Google Scholar
• Martilia M, Vuolteenaho O, Ganten D. Synthesis and secretion of natriuretic peptides in the hypertensive TGR(mREN2)27 transgenic rat. Hypertension. 1996; 28: 995–1004
   PubMedGoogle Scholar
• Messerli F H, Glade L B, Ventura H O. Diurnal variations of circadian rhythm, arterial pressure, and urinary catecholamines in borderline and established essential hypertension. Am Heart J. 1982; 104: 109–14
   PubMed Web of Science ®Google Scholar
• Middeke M. Synchronizität von zirkadianer Blutdruckrhythmik und symphatoadrenerger Aktivität. Z Kardiol. 1992; 81: 55–58, (Suppl 2)
   PubMedGoogle Scholar
• Middeke M, Schrader J. Nocturnal blood pressure in normotensive subjects and those with white coat, primary, and secondary hypertension. Br Med J. 1994; 308: 630–32
   PubMed Web of Science ®Google Scholar
• Mikuni M, Saito Y, Koyama T. Circadian variations in plasma 3′:5′-cyclic adenosine monophosphate and 3′5′-cyclic guanosine monophoshate in normal adults. Life Sci. 1978; 22: 667–72
   PubMedGoogle Scholar
• Moncada S, Palmer R MJ, Higgs E A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991; 43: 109–42
   PubMed Web of Science ®Google Scholar
• Moncada S, Randomski M W, Palmer R MJ. Endothelium-derived relaxing factor: Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol. 1988; 37: 2495–2501
   PubMed Web of Science ®Google Scholar
• Mullins J J, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 renin gene. Nature 1990; 344: 541–44
   PubMed Web of Science ®Google Scholar
• Murad F. Cyclic guanosine monophoshate as a mediator of vasodilation. J Clin Invest. 1986; 92: 1–5
   Google Scholar
• Pons M, Schnecko A, Witte K. Circadian rhythms in renal function in hypertensive TGR(mRen-2)27 and their normotensive controls. Am J Physiol. 1996; 271: R1002–8
   PubMedGoogle Scholar
• Portaluppi F, Bagni B, Uberti E. Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, blood pressure and heart rate in normal and hypertensive subjects. J Hypertens. 1990; 8: 85–95
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Montanari L, Vergnani L. Loss of nocturnal increase in plasma concentration of atrial natriuretic peptide in hypertensive chronic renal failure. Cardiology. 1992; 80: 312–23
   PubMed Web of Science ®Google Scholar
• Reid J L, Rubin P C. Catecholamines and blood pressure. Handbook of experimental pharmacology, Vol. 90/II, Catecholamines II, U Trendelenburg, N Weiner. Springer Verlag, Berlin 1989; 319–44
   Google Scholar
• Richards A M, Wittert G, Espiner E A. Prolonged inhibition of endopeptidae 24.11 in normal man: renal, endocrine and haemodynamic effects. J Hypertens. 1991; 9: 955–62
   PubMed Web of Science ®Google Scholar
• Schnecko A, Witte K, Lemmer B. Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats. J Cardiovasc Pharmacol. 1995; 26: 214–21
   PubMed Web of Science ®Google Scholar
• Schnecko A, Witte K, Schänzer A. Circadian rhythm in plasma renin and converting enzyme activity, corticosterone and aldosterone concentration in normotensive Sprague Dawley and transgenic hypertensive rats. Biol Rhythm Res. 1995; 26: 442
   Google Scholar
• Springate J E, Feld L G, Ganten D. Renal function in hypertensive rats transgenic for mouse renin gene. Am J Physiol. 1994; 266: F731–37
   PubMed Web of Science ®Google Scholar
• Springate J E, Feld L G, Ganten D. Enalapril and renal function in hypertensive rats transgenic for mouse renin gene. Hypertension. 1997; 30: 868–72
   PubMedGoogle Scholar
• Steiner A S, Parker C W, Kipnis D M. Radioimmunoassay for cyclic nucleotides. J BiolChem. 1972; 247: 1106
   PubMed Web of Science ®Google Scholar
• Struijkerboudier H AJ, Vanessen H, Fazzi G. Disproportional arterial hypertrophy in hypertensive mRen-2 transgenic rats. Hypertension. 1996; 28: 779–84
   PubMedGoogle Scholar
• Suzuki H, Ikenaga H, Hishikawa K. Increases in NO−2/NO−3 excretion in the urine as an indicator of endothelium-derived relaxing factor during elevation of blood pressure. Clin Sci. 1992; 82: 631–34
   PubMed Web of Science ®Google Scholar
• Tikkanen I, Fyhrquist F. Nitric oxide in hypertension and renal diseases. Ann Med. 1995; 27: 353–57
   PubMed Web of Science ®Google Scholar
• Timio M, Venanzi S, Lolli S. “Non-dipper” hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clin Nephrol. 1995; 43: 382–87
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Guerrieri M. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990; 81: 528–36
   PubMed Web of Science ®Google Scholar
• Vesely D L, Giordano A T. Food intake and body positional change alter the circadian rhythm of atrial natriuretic peptides excretion into human urine. Chronobiol Int. 1991; 8(5)373–84
   PubMed Web of Science ®Google Scholar
• Villarreal F J, Mackenna D A, Omens J H. Myocardial remodeling in hypertensive Ren-2 transgenic rats. Hypertension. 1995; 25: 98–104
   PubMed Web of Science ®Google Scholar
• Weicker H, Feraudi M, Hägele H. Electrochemical detection of catecholamines in urine and plasma after separation with HPLC. Clin Chim Acta. 1984; 141: 17
   PubMed Web of Science ®Google Scholar
• Weil J, Strom T M, Lang R E. Influence of diurnal rhythm, posture and right atrial size on plasma atrial natriuretic peptide levels. Z Kardiol. 1988; 77: 36–40, (Suppl 2)
   PubMedGoogle Scholar
• Witte K, Lemmer B. Free-running rhythms in blood pressure and heart rate in normotensive and transgenic hypertensive rats. Chronobiol Int. 1995; 12: 237–47
   Web of Science ®Google Scholar
• Witte K, Lemmer B. Rhythms in second messenger mechanisms. Handbook of experimental pharmacology, Vol. 125, physiology and pharmacology of biological rhythms, P H Redfern, B Lemmer. Springer Verlag, Berlin 1997; 136–56
   Google Scholar
• Witte K, Schnecko A, Perbandt K. Signal transduction in cardiac and vascular tissue from normotensive and transgenic hypertensive TGR(mREN2)27 rats. Eur J Pharmacol. 1998; 341: 3374
   Google Scholar